Quick Takeaways
- Linda M. Richardson has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value is not available.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Linda M. Richardson and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ALT | Altimmune, Inc. | Chief Commercial Officer | 16 Sep 2025 | |||
| ICPT | INTERCEPT PHARMACEUTICALS, INC. | EVP & Chief Commercial Officer | 08 Nov 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|